Mordenti J, Ries C, Brooks G F, Unadkat N, Tseng A
Am J Med. 1986 Feb;80(2):333-5. doi: 10.1016/0002-9343(86)90037-9.
Neutropenia associated with intravenous vancomycin therapy is reported in a patient with chronic myelogenous leukemia. The patient received 12 days of vancomycin therapy without incidence; however, a second course of vancomycin initiated on hospital day 14 produced severe neutropenia. This delayed onset is typical of vancomycin-induced neutropenia. The neutropenia reversed, without complications, as soon as the vancomycin was discontinued.
